CardioMetabolic Program Meets eHealth: Redesign and Evaluation for Optimal Reach and Impact
CardioMetabolic Program Meets eHealth: Redesign and Evaluation for Optimal Reach and Impact
The eCMP Pilot aims to study the feasibility and potential effectiveness of an
 electronically-mediated CardioMetabolic Program (eCMP) for therapeutic lifestyle change among
 adults with or at high risk for type 2 diabetes, heart disease, and/or stroke.
The eCMP is an evidence-based lifestyle intervention using a holistic,
 mind-body-spirit-based, and multidisciplinary approach, and it will be delivered using
 existing web and mobile technologies. In this pragmatic randomized controlled trial,
 participants will be recruited from primary care patients of an integrated ambulatory care
 system. They will be randomly assigned to receive the eCMP upon completion of baseline data
 collection (the Immediate Intervention group) or after 3 months (the Delayed Intervention
 group). All participants will be assessed at 0, 3 and 6 months. Outcomes include common
 cardiometabolic risk factors (e.g., weight, blood pressure, and fasting plasma glucose),
 health behaviors (e.g., dietary intake and physical activity), and indicators of eCMP
 engagement and adherence (e.g., attendance and self-monitoring).
Inclusion Criteria:

 -  English-speaking adults aged 18+ years

 -  High-risk primary prevention: BMI 35+ and prediabetes (including hx of gestational
 diabetes) and/or metabolic syndrome

 -  Secondary prevention: BMI 30+ and type 2 diabetes and/or cardiovascular disease

 -  Able and willing to provide written informed consent

 Exclusion Criteria:

 -  Medical determination that the study is inappropriate or unsafe for the patient

 -  Type 1 diabetes

 -  Safety concerns related to significant physical or mental health issues or life
 expectancy of less than 12 months

 -  Currently pregnant or lactating

 -  No regular telephone or broadband Internet access or otherwise unable to participate
 in the intervention